Archive for microbiome
Microbiome therapeutics: 6 takeaways from a MassBio panel
Seeing the surprising success of “poop pills” in gastrointestinal C. difficile infection, pharma companies and startups are embracing the microbiome as a new therapeutic target for an astonishing range of maladies. To learn what pioneering companies in the space are thinking about the hope and the hype, Vector recently attended a panel on microbiome therapeutics ... Read More about Microbiome therapeutics: 6 takeaways from a MassBio panel
Respiratory illness in children with gastroesophageal reflux: Are acid blockers part of the problem?
Gastroesophageal reflux disease (GERD), in which stomach acids back up into the esophagus, is increasingly diagnosed in children. One study based on insurance-claims data found that GERD diagnoses in infants more than tripled between 2000 and 2005 (from 3.4 to 12.3 percent). In addition to heartburn and chest pain, GERD has been implicated in cough, wheezing ... Read More about Respiratory illness in children with gastroesophageal reflux: Are acid blockers part of the problem?
Frozen poop pill offers a less invasive treatment option for emerging infectious disease
The fecal microbiota transplantation (FMT) movement is catching the attention of scientists, researchers and the media nationwide. Currently, fecal transplantation delivers pre-screened, healthy human donor stool to a patient via colonoscopy or by nasogastric tube. It’s prescribed as an effective alternative to long-term antibiotic use in treating debilitating infectious diseases such as Clostridium difficile, also known ... Read More about Frozen poop pill offers a less invasive treatment option for emerging infectious disease